The Sussex Cancer Network is trying to improve the antiemetic care of patients to counter the unpleasant side effects of cytotoxic drugs during cancer treatment
Cytotoxic drugs are a mainstay of cancer treatment, but their unpleasant side effects, including nausea and vomiting, are well documented. Antiemetic strategies have been developed to counter these effects, but there is still scope for improvement. This article discusses the steps taken by the Sussex Cancer Network to investigate and improve the antiemetic care of patients receiving chemotherapy.
Cancer Nursing Practice. 12, 8, 24-29. doi: 10.7748/cnp2013.10.12.8.24.e1001
Correspondence Peer reviewThis article has been subject to double blind peer review
Conflict of interestThe audits were funded by the Sussex Cancer Network. At the time the audits were undertaken, both authors were employed by the network and were responsible for initiating and running the audit programme. Writing support was provided by Acumen Healthcare Communications, funded by Sinclair IS Pharma. Sinclair IS Pharma had no influence on audit conduct or any editorial input into the writing of the article. Kingsley Wildman has previously acted as a consultant for Sinclair IS Pharma. Clare Dikken has no conflict of interest to declare
Received: 24 May 2013
Accepted: 18 July 2013
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
